MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study

Distinguishing non-specific signs and symptoms of acromegaly from treatment emergent adverse events (TEAEs) in patients treated with somatostatin receptor ligands has proven difficult given limited data from placebo-controlled studies. The phase 3 Octreotide capsules versus Placebo Treatment In Mult...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Labadzhyan, Artak, Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ludlam, William Henry, Patou, H, Haviv, Asi, Waligorska, Agata Baldys, Biermasz, Nienke, Trainer, Peter James, Kennedy, Laurence, Melmed, Shlomo, Strasburger, Christian Joseph
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Neuroendocrinology and Pituitary
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208021/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1870
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items